<DOC>
	<DOC>NCT01088594</DOC>
	<brief_summary>A single centre, open, randomized, placebo controlled, 3 period cross-over study to evaluate the effects of single oral doses of pioglitazone 45mg, rosiglitazone 8mg and placebo on urinary sodium excretion in 12 healthy male volunteers</brief_summary>
	<brief_title>A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Inclusion Criteria Volunteers with Body Mass Index 18.028.0 kg/m2 Exclusion Criteria Clinically relevant medical history</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>urinary sodium excretion</keyword>
	<keyword>Pioglitazone</keyword>
	<keyword>Rosiglitazone</keyword>
	<keyword>Methodological study</keyword>
</DOC>